Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 138 | $77,751,392 |
| Sells | 187 | $105,535,934 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 12 Mar 2025 | Sale | 1,587 | 330.5356 | 524,560 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 12 Mar 2025 | Sale | 2,759 | 331.3594 | 914,221 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 12 Mar 2025 | Sale | 2,382 | 332.3785 | 791,726 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 12 Mar 2025 | Sale | 800 | 333.6575 | 266,926 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 12 Mar 2025 | Sale | 200 | 334.97 | 66,994 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 13 Mar 2025 | Sale | 1,951 | 322.4498 | 629,100 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 13 Mar 2025 | Sale | 1,649 | 323.4651 | 533,394 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 13 Mar 2025 | Sale | 900 | 324.6867 | 292,218 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 13 Mar 2025 | Sale | 800 | 325.6263 | 260,501 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 13 Mar 2025 | Sale | 1,000 | 327.6268 | 327,627 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 13 Mar 2025 | Sale | 400 | 328.6812 | 131,472 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 13 Mar 2025 | Sale | 967 | 329.8601 | 318,975 | D |
| 14 Mar 2025 16:25 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 13 Mar 2025 | Sale | 75 | 330.225 | 24,767 | D |
| 12 Mar 2025 16:32 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DIER MARDI | SVP and CFO | 10 Mar 2025 | Sale | 258 | 323.04 | 83,344 | D |
| 07 Mar 2025 17:40 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 05 Mar 2025 | Sale | 900 | 335.1459 | 301,631 | D |
| 07 Mar 2025 17:40 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 05 Mar 2025 | Sale | 1,777 | 336.7795 | 598,457 | D |
| 07 Mar 2025 17:40 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 05 Mar 2025 | Sale | 1,146 | 338.091 | 387,452 | D |
| 07 Mar 2025 17:40 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 05 Mar 2025 | Sale | 400 | 339.6843 | 135,874 | D |
| 07 Mar 2025 17:40 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 05 Mar 2025 | Sale | 1,657 | 340.7525 | 564,627 | D |
| 07 Mar 2025 17:40 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 05 Mar 2025 | Sale | 1,043 | 341.8376 | 356,537 | D |
| 07 Mar 2025 17:40 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 05 Mar 2025 | Sale | 1,077 | 342.8967 | 369,300 | D |
| 07 Mar 2025 17:40 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 05 Mar 2025 | Sale | 4,701 | 343.8479 | 1,616,429 | D |
| 07 Mar 2025 17:40 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 05 Mar 2025 | Sale | 1,412 | 344.757 | 486,797 | D |
| 05 Mar 2025 16:36 | MDGL | MADRIGAL PHARMACEUTICALS Inc | KELLEY SHANNON T | General Counsel | 03 Mar 2025 | Sale | 415 | 335 | 139,025 | D |
| 05 Mar 2025 16:31 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DIER MARDI | SVP and CFO | 03 Mar 2025 | Sale | 1,187 | 325.89 | 386,831 | D |
| 05 Mar 2025 16:31 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DIER MARDI | SVP and CFO | 03 Mar 2025 | Sale | 774 | 323.5357 | 250,417 | D |
| 05 Mar 2025 16:24 | MDGL | MADRIGAL PHARMACEUTICALS Inc | HUNTSMAN CAROLE | Chief Commercial Officer | 03 Mar 2025 | Sale | 71 | 313.08 | 22,229 | D |
| 05 Mar 2025 16:24 | MDGL | MADRIGAL PHARMACEUTICALS Inc | HUNTSMAN CAROLE | Chief Commercial Officer | 03 Mar 2025 | Sale | 200 | 314.74 | 62,948 | D |
| 05 Mar 2025 16:24 | MDGL | MADRIGAL PHARMACEUTICALS Inc | HUNTSMAN CAROLE | Chief Commercial Officer | 03 Mar 2025 | Sale | 300 | 320.21 | 96,063 | D |
| 05 Mar 2025 16:24 | MDGL | MADRIGAL PHARMACEUTICALS Inc | HUNTSMAN CAROLE | Chief Commercial Officer | 03 Mar 2025 | Sale | 200 | 323.65 | 64,730 | D |
| 05 Mar 2025 16:24 | MDGL | MADRIGAL PHARMACEUTICALS Inc | HUNTSMAN CAROLE | Chief Commercial Officer | 03 Mar 2025 | Sale | 200 | 324.59 | 64,918 | D |
| 05 Mar 2025 16:24 | MDGL | MADRIGAL PHARMACEUTICALS Inc | HUNTSMAN CAROLE | Chief Commercial Officer | 03 Mar 2025 | Sale | 100 | 326.34 | 32,634 | D |
| 05 Mar 2025 16:24 | MDGL | MADRIGAL PHARMACEUTICALS Inc | HUNTSMAN CAROLE | Chief Commercial Officer | 03 Mar 2025 | Sale | 100 | 327.49 | 32,749 | D |
| 05 Mar 2025 16:24 | MDGL | MADRIGAL PHARMACEUTICALS Inc | HUNTSMAN CAROLE | Chief Commercial Officer | 03 Mar 2025 | Sale | 100 | 329.64 | 32,964 | D |
| 05 Mar 2025 16:24 | MDGL | MADRIGAL PHARMACEUTICALS Inc | HUNTSMAN CAROLE | Chief Commercial Officer | 03 Mar 2025 | Sale | 563 | 335 | 188,605 | D |
| 04 Mar 2025 21:24 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 28 Feb 2025 | Sale | 1,052 | 340.9857 | 358,717 | D |
| 04 Mar 2025 21:24 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 28 Feb 2025 | Sale | 175 | 341.5491 | 59,771 | D |
| 28 Feb 2025 16:31 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 27 Feb 2025 | Sale | 398 | 346.9031 | 138,067 | D |
| 28 Feb 2025 16:31 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 27 Feb 2025 | Sale | 14,302 | 347.39 | 4,968,372 | D |
| 28 Feb 2025 16:31 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 27 Feb 2025 | Sale | 770 | 348.9433 | 268,686 | D |
| 28 Feb 2025 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 27 Feb 2025 | Sale | 100 | 351.0073 | 35,101 | D |
| 28 Feb 2025 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 27 Feb 2025 | Sale | 500 | 351.99 | 175,995 | D |
| 28 Feb 2025 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 27 Feb 2025 | Sale | 238 | 353.8345 | 84,213 | D |
| 28 Feb 2025 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 27 Feb 2025 | Sale | 8,545 | 355.079 | 3,034,150 | D |
| 28 Feb 2025 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 27 Feb 2025 | Sale | 2,791 | 356.5089 | 995,016 | D |
| 28 Feb 2025 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 27 Feb 2025 | Sale | 2,038 | 357.2664 | 728,109 | D |
| 28 Feb 2025 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 27 Feb 2025 | Sale | 3,548 | 358.3311 | 1,271,359 | D |
| 28 Feb 2025 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 27 Feb 2025 | Sale | 2,024 | 359.2106 | 727,042 | D |
| 28 Feb 2025 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 27 Feb 2025 | Sale | 216 | 360.0662 | 77,774 | D |
| 27 Jan 2025 17:18 | MDGL | MADRIGAL PHARMACEUTICALS Inc | HUNTSMAN CAROLE | Chief Commercial Officer | 24 Jan 2025 | Sale | 347 | 335.24 | 116,328 | D |
| 27 Jan 2025 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SIBOLD WILLIAM JOHN | President and CEO | 24 Jan 2025 | Sale | 1,584 | 335.24 | 531,020 | D |
| 27 Jan 2025 17:07 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 24 Jan 2025 | Sale | 648 | 335.24 | 217,236 | D |
| 27 Jan 2025 17:03 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 24 Jan 2025 | Sale | 103 | 335.24 | 34,530 | D |
| 17 Jan 2025 19:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | KELLEY SHANNON T | General Counsel | 17 Jan 2025 | Sale | 277 | 273.41 | 75,735 | D |
| 17 Jan 2025 19:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 17 Jan 2025 | Sale | 442 | 273.41 | 120,847 | D |
| 17 Jan 2025 19:05 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 17 Jan 2025 | Sale | 1,689 | 273.41 | 461,789 | D |
| 05 Dec 2024 16:46 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 03 Dec 2024 | Sale | 3,080 | 315.2116 | 970,852 | I |
| 05 Dec 2024 16:46 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 03 Dec 2024 | Sale | 520 | 315.9038 | 164,270 | I |
| 27 Nov 2024 16:16 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 25 Nov 2024 | Sale | 2,200 | 350.0775 | 770,170 | I |
| 27 Nov 2024 16:16 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 25 Nov 2024 | Sale | 1,200 | 350.7146 | 420,858 | I |
| 22 Nov 2024 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | HUNTSMAN CAROLE | Chief Commercial Officer | 21 Nov 2024 | Sale | 688 | 316.92 | 218,041 | D |
| 08 Nov 2024 17:07 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 07 Nov 2024 | Sale | 5,000 | 350 | 1,750,000 | D |
| 05 Nov 2024 19:01 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Nov 2024 | Sale | 2,800 | 300.0993 | 840,278 | D |
| 05 Nov 2024 19:01 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Nov 2024 | Sale | 1,100 | 301.2173 | 331,339 | D |
| 05 Nov 2024 19:01 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Nov 2024 | Sale | 800 | 302.2488 | 241,799 | D |
| 05 Nov 2024 19:01 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Nov 2024 | Sale | 300 | 304.291 | 91,287 | D |
| 11 Sep 2024 21:51 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SIBOLD WILLIAM JOHN | President and CEO | 09 Sep 2024 | Sale | 6,363 | 243.83 | 1,551,490 | D |
| 18 Jun 2024 21:39 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 14 Jun 2024 | Sale | 1,900 | 280 | 532,000 | D |
| 14 Jun 2024 21:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 12 Jun 2024 | Sale | 2,000 | 285 | 570,000 | D |
| 23 May 2024 21:36 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 21 May 2024 | Sale | 1,036 | 231.34 | 239,668 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,000 | 218.9945 | 218,994 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 100 | 219.9 | 21,990 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,100 | 217.8553 | 239,641 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 721 | 216.9838 | 156,445 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,804 | 214.6815 | 387,285 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 375 | 216.0836 | 81,031 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 2,190 | 213.8548 | 468,342 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,363 | 212.8513 | 290,116 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 5,009 | 211.844 | 1,061,127 | D |
| 16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 8,827 | 210.9926 | 1,862,432 | D |
| 10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 200 | 248.58 | 49,716 | D |
| 10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 407 | 247.7582 | 100,838 | D |
| 10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 600 | 246.9773 | 148,186 | D |
| 10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 945 | 244.7881 | 231,325 | D |
| 10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 300 | 245.6867 | 73,706 | D |
| 10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 224 | 243.245 | 54,487 | D |
| 10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 4,866 | 248.5907 | 1,209,642 | D |
| 10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 5,028 | 246.959 | 1,241,710 | D |
| 10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 3,464 | 247.7601 | 858,241 | D |
| 10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 2,078 | 245.7126 | 510,591 | D |
| 10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 5,663 | 244.8607 | 1,386,646 | D |
| 10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 3,730 | 244.1197 | 910,566 | D |
| 10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 1,441 | 242.9523 | 350,094 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 5,278 | 245.5332 | 1,295,924 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 2,079 | 244.4509 | 508,213 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 8,817 | 242.6073 | 2,139,069 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 8,989 | 243.3294 | 2,187,288 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 700 | 241.1413 | 168,799 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 1,643 | 240.1076 | 394,497 | D |
| 05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 100 | 248.23 | 24,823 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)